Oxford Biomedica


Oxford Biomedica is your trusted partner for viral vector development scale-up, analytics and GMP processing, producing life-changing cell and gene treatments.

Our expertise and state-of-the-art bioprocessing facilities help to achieve commercialisation of your viral vector-based products.

We develop and manufacture in vivo and ex vivo products, both in-house and with partners including Novartis, Bristol Myers Squibb, Beam Therapeutics, and Boehringer Ingelheim.

Discover how we drive credible science to help you realise incredible results at www.oxb.com.